What is he best known for?
The fields of study he is best known for:
Peter Igarashi mainly investigates Kidney, Cell biology, Internal medicine, Endocrinology and Polycystic kidney disease.
His Kidney research incorporates elements of Reperfusion injury, Molecular biology, Acute kidney injury and Pathology.
The study incorporates disciplines such as Genetics, Gene, Tubule and Kidney morphogenesis in addition to Cell biology.
His Internal medicine research integrates issues from Sodium–hydrogen antiporter, Brush border and Transcellular.
His Endocrinology study combines topics from a wide range of disciplines, such as Fibrosis, Intracellular pH and Phosphorylation.
His Polycystic kidney disease study integrates concerns from other disciplines, such as Cyst, Kidney disease, Pathogenesis, Cilium and Regulation of gene expression.
His most cited work include:
- Kidney-specific inactivation of the KIF3A subunit of kinesin-II inhibits renal ciliogenesis and produces polycystic kidney disease (477 citations)
- Genetics and Pathogenesis of Polycystic Kidney Disease (459 citations)
- HOXA10 is expressed in response to sex steroids at the time of implantation in the human endometrium. (442 citations)
What are the main themes of his work throughout his whole career to date?
Kidney, Molecular biology, Cell biology, Internal medicine and Endocrinology are his primary areas of study.
His Kidney research is multidisciplinary, incorporating elements of Cancer research, Transgene, Pathology, Intracellular pH and Acute kidney injury.
His biological study spans a wide range of topics, including Epithelium, Gene expression, Hepatocyte nuclear factors, Biochemistry and Complementary DNA.
His studies deal with areas such as Regulation of gene expression, Transcription factor and Alternative splicing as well as Gene expression.
His Cell biology research incorporates themes from Cleavage, Gene, Cellular differentiation and Kidney development.
The concepts of his Polycystic kidney disease study are interwoven with issues in Cyst, Kidney cysts, Cilium and Pathogenesis.
He most often published in these fields:
- Kidney (39.04%)
- Molecular biology (30.14%)
- Cell biology (32.88%)
What were the highlights of his more recent work (between 2012-2021)?
- Internal medicine (34.25%)
- Cell biology (32.88%)
- Endocrinology (28.77%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Cell biology, Endocrinology, Hepatocyte nuclear factors and Cystic kidney.
His is involved in several facets of Internal medicine study, as is seen by his studies on Kidney, Polycystic kidney disease, Kidney disease and Nephrology.
The Kidney study combines topics in areas such as Creatinine, Organogenesis and Mutant.
His work deals with themes such as Cyst, Kidney cysts, Autosomal dominant polycystic kidney disease and Cilium, which intersect with Polycystic kidney disease.
His Cell biology research focuses on subjects like Gene, which are linked to Embryo and Stem cell.
His studies in Molecular biology integrate themes in fields like Regulation of gene expression and Genetically modified mouse.
Between 2012 and 2021, his most popular works were:
- Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease (195 citations)
- miR-17∼92 miRNA cluster promotes kidney cyst growth in polycystic kidney disease (112 citations)
- microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism (88 citations)
In his most recent research, the most cited papers focused on:
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Autosomal dominant polycystic kidney disease, Polycystic kidney disease and Cystic kidney.
His Internal medicine research focuses on Kidney, Cystic kidney disease and Fibrosis.
His Kidney study combines topics in areas such as Nephrology and Mutant, Gene.
His Endocrinology research focuses on Cancer research and how it connects with Nephronophthisis.
The PKD1 study which covers Mutation that intersects with Cell biology.
Peter Igarashi combines subjects such as Cilium and microRNA with his study of Cyst.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
